ImaCor Awarded Federal Supply Schedule Contract for ClariTEE® Probe

Only system of its kind to enable on-demand, direct imaging in critically ill patients will be available to DoD, VA facilities across the U.S.

GARDEN CITY, N.Y.--(BUSINESS WIRE)-- ImaCor, Inc., the developer of the first and only hemodynamic transesophageal echocardiographic (HTEE™) management system, today announced it has been awarded a Federal Supply Schedule (FSS) contract for the ImaCor ClariTEE® probe by the Department of Veteran Affairs (VA).

The five-year FSS contract supports the delivery of HTEE technology into the critical care centers of the Department of Defense and the VA, one of the largest integrated health care delivery systems in the country with over 170 hospitals.

“We welcome this opportunity to add VA and Department of Defense hospitals to our growing list of civilian customers that are successfully using HTEE technology to address the burden of hemodynamic instability, thereby ensuring improved patient management,” said Peter Pellerito, President and CEO of ImaCor.

The ClariTEE miniaturized transesophageal probe can be placed in a patient for on-demand imaging over an extended period of time. This disposable TEE probe is the first of its kind in the world, enabling direct visualization of cardiac function in critically ill patients. It provides gold standard TEE hemodynamic assessment indwelling for up to 72 hours, supporting both optimal patient care and reduced care costs.

About ImaCor

ImaCor, Inc. is a privately held company headquartered in Garden City, NY. The company designs, manufactures, and distributes advanced solutions for hemodynamic management in the critical care environment for the purpose of improving patient outcomes. ImaCor manufactures the ClariTEE® probe, the only miniaturized, indwelling TEE probe suitable for long-term clinical settings. ClariTEE® is a registered trademark of ImaCor, Inc. For more information, please visit our website at www.imacormonitoring.com.



CONTACT:

Media Inquiries
ImaCor, Inc.
Jennifer D. Kujawski
Director, Market Research & Public Relations
[email protected]
(516) 393.0970

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Cardiology  Hospitals  Medical Devices  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.